-
Barclays Sees 29% Upside For Premier, Starts At Overweight
Wednesday, June 1, 2016 - 10:18am | 354Read More...Barclays has initiated coverage of Premier Inc (NASDAQ: PINC) with an Overweight rating and $41 price target, implying 29 percent appreciation from current levels. Premier operates as a healthcare improvement company in the United States. The company operates healthcare group purchasing...
-
Oppenheimer Reiterates Outperform and PT of $21 on MedAssets
Thursday, June 30, 2011 - 9:52am | 43Read More...Oppenheimer reiterated its Outperform rating on MedAssets (NASDAQ: MDAS). At the same time, Oppenheimer left its price target on the company's stock unchanged at $21. In today's trading, MedAssets added 0.04% to its value to trade around $13.20.
-
Deutsche Bank Updates 6/29/11
Wednesday, June 29, 2011 - 7:59am | 829Read More...Deutsche Bank made a number of updates in a research report published today. Legg Mason (NYSE: LM) had its rating upgraded from Hold to Buy. At the same time, its price target was raised from $36 to $38. On Tuesday, Legg Mason added 0.5% to its value to end the day at $31.94....
-
JP Morgan Lowers PT On MedAssets To $18
Thursday, May 5, 2011 - 7:36am | 26Read More...JP Morgan has lowered the price target on MedAssets (NASDAQ: MDAS) from $20 to $18 and maintains its Neutral rating.
-
Piper Jaffray Updates Model on MedAssets (MDAS)
Wednesday, March 30, 2011 - 9:31am | 123Read More...Piper Jaffray is out with its report today on MedAssets (NASDAQ: MDAS), updating its model on MDAS. In a note to clients, Piper Jaffray writes, "We are distributing operating expenses more evenly across quarters and updating Acquisition related charges to be less 1H heavy, while keeping the $25...
-
Citigroup has lowered the price target on MedAssets, Inc
Tuesday, March 22, 2011 - 6:40am | 26Read More...Citigroup has lowered the price target on MedAssets, Inc. (NASDAQ: MDAS) from $20 to $17 and maintains its Hold rating.
-
Deutsche Bank Lowers PT On MedAssets To $19
Friday, February 25, 2011 - 9:06am | 26Read More...Deutsche Bank has lowered the price target on MedAssets (NASDAQ: MDAS) from $27 to $19 and maintains its Hold rating.
-
Citigroup Downgrades MedAssets To Hold, PT To $20
Friday, February 25, 2011 - 8:25am | 26Read More...Citigroup has downgraded MedAssets (NASDAQ: MDAS) from Buy to Hold and has lowered the price target from $26 to $20.
-
Auriga Lowers MDAS Target From $26 To $22
Friday, February 25, 2011 - 8:20am | 26Read More...Auriga is lowering its PT on shares of MedAssets, Inc. (NASDAQ: MDAS) from $26 to $22. MedAssets closed Thursday at $21.32.
-
Piper Jaffray Downgrades MedAssets To Underweight, PT To $15
Friday, February 25, 2011 - 8:04am | 28Read More...Piper Jaffray has downgraded MedAssets, Inc. (NASDAQ: MDAS) from Neutral to Underweight and has lowered the price target from $21 to $15.
-
Jefferies Reiterates MedAssets Rating
Wednesday, December 1, 2010 - 8:27am | 79Read More...Jefferies & Company said today that it is reiterating its Hold rating on shares of MedAssets, Inc. (NASDAQ: MDAS). “We continue to believe that MDAS is well positioned in the healthcare market with a focus on cost-savings and revenue cycle,” Jefferies writes. “However, with moving parts such...
-
MedAssets Signs Reseller Agreement; Citigroup Maintains Estimates, Buy Rating and Price Target
Tuesday, October 12, 2010 - 7:51am | 126Read More...Citigroup has stated that it maintains its estimates, Buy rating and $29 price target for MedAssets, Inc. (NASDAQ: MDAS) following an announcement from Cerner Corporation's (NASDAQ: CERN). Cerner has signed an agreement to market MedAssets' full suite of Web-based revenue technology solutions. “To...
-
Coverage Initiated For AH, MDAS By Brean Murray
Wednesday, September 29, 2010 - 9:22am | 72Read More...Brean Murray Carret & Co. has initiated coverage for the following companies: Accretive Health Inc. (NYSE: AH) Hold, N/A price target, $10.81 MedAssets, Inc. (NASDAQ: MDAS) Buy, $25 price target, $20.37 Is AAPL a Buy, Sell or Hold? Click Here.
